Robbert J C Slebos

7PUBLICATIONS
96CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsVirtual and mixed reality
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 21, 2025
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer.

Ritu Chaudhary, Graydon Moorhead, Robin Park

|Jun 24, 2025
PV-10 Triggers Immunogenic Cell Death in Head and Neck Squamous Cell Carcinoma via Endoplasmic Reticulum Stress and Apoptosis.

Sowjanya Thatikonda, Ritu Chaudhary, Yeva Meshkovska

|Aug 21, 2024
Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis.

Nabil F Saba, Ritu Chaudhary, Kedar Kirtane

|Jul 26, 2024
Preexisting Skin-Resident CD8 and γδ T-cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy Efficacy.

Zachary Z Reinstein, Yue Zhang, Oscar E Ospina

|Jul 26, 2023
Virtual alignment of pathology image series for multi-gigapixel whole slide images.

Chandler D Gatenbee, Ann-Marie Baker, Sandhya Prabhakaran

|Jun 28, 2023
EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma.

Ritu Chaudhary, Robbert J C Slebos, Leenil C Noel

Pageof 2

Frequent Collaborators

6 joint publications

Christine H Chung

4 joint publications

Ritu Chaudhary

4 joint publications

Maria I Poole

3 joint publications

Xiaofei Song